ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SWTX SpringWorks Therapeutics Inc

46.45
0.00 (0.00%)
Pre Market
Last Updated: 06:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 42.00
Ask Price 52.00
News -
Day High

Low
18.00

52 Week Range

High
53.92

Day Low
Share Name Share Symbol Market Stock Type
SpringWorks Therapeutics Inc SWTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 46.45 06:00:00
Open Price Low Price High Price Close Price Previous Close
46.45
Trades Shares Traded Average Volume 52 Week Range
0 0 - 18.00 - 53.92
Last Trade Type Quantity Price Currency
- 0 US$ 46.45 USD

SpringWorks Therapeutics (SWTX) Options Flow Summary

Overall Flow

Bearish

Net Premium

-746k

Calls / Puts

0.00%

Buys / Sells

60.00%

OTM / ITM

14.29%

Sweeps Ratio

0.00%

SpringWorks Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.43B 73.79M - 5.45M -325.1M -4.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

SpringWorks Therapeutics News

Date Time Source News Article
4/24/202412:31GlobeNewswire Inc.SpringWorks Therapeutics Announces Abstracts Accepted for..
4/18/202406:00GlobeNewswire Inc.SpringWorks Therapeutics to Report First Quarter 2024..
3/04/202405:30GlobeNewswire Inc.SpringWorks Therapeutics Initiates Rolling Submission of New..
3/01/202416:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/29/202407:30GlobeNewswire Inc.SpringWorks Therapeutics Announces European Medicines Agency..
2/27/202407:28Edgar (US Regulatory)Form 8-K - Current report
2/27/202407:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/27/202406:29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
2/27/202405:51Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/202405:44Edgar (US Regulatory)Form 8-K - Current report
2/27/202405:30GlobeNewswire Inc.SpringWorks Therapeutics Reports Fourth Quarter and Full..
2/22/202406:00GlobeNewswire Inc.SpringWorks Therapeutics to Present at Upcoming Investor..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SWTX Message Board. Create One! See More Posts on SWTX Message Board See More Message Board Posts

Historical SWTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week42.8847.2541.9144.79811,8553.578.33%
1 Month46.4847.4138.9043.88765,472-0.03-0.06%
3 Months48.1053.9238.9048.051,139,375-1.65-3.43%
6 Months22.0453.9218.0039.011,212,13924.41110.75%
1 Year23.4453.9218.0034.95905,18323.0198.17%
3 Years72.6789.745813.6036.15713,789-26.22-36.08%
5 Years24.5096.4813.6038.79545,48821.9589.59%

SpringWorks Therapeutics Description

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

Your Recent History

Delayed Upgrade Clock